NTLA - Intellia Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts24242726
Avg. Estimate-1.32-1.38-5.36-5.76
Low Estimate-1.59-1.74-6.49-8.42
High Estimate-1.15-1.11-4.55-4.05
Year Ago EPS-1.33-1.49-6.16-5.36
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts21212827
Avg. Estimate12.08M11.85M47.99M49.88M
Low EstimateN/AN/A12.6MN/A
High Estimate30M30M102.6M120M
Year Ago Sales14.03M11.34M52.12M47.99M
Sales Growth (year/est)-13.90%4.50%-7.90%3.90%
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-1.31-1.28-1.39-1.4
EPS Actual-1.33-1.49-1.4-1.17
Difference-0.02-0.21-0.010.23
Surprise %-1.50%-16.40%-0.70%16.40%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-1.32-1.38-5.36-5.76
7 Days Ago-1.33-1.39-5.39-5.78
30 Days Ago-1.44-1.49-5.87-6.09
60 Days Ago-1.44-1.49-5.87-6.08
90 Days Ago-1.44-1.49-5.87-6.03
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 Days1111
Up Last 30 Days1010157
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNTLAIndustrySector(s)S&P 500
Current Qtr.0.80%N/AN/AN/A
Next Qtr.7.40%N/AN/AN/A
Current Year13.00%N/AN/AN/A
Next Year-7.50%N/AN/AN/A
Next 5 Years (per annum)30.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A